CSF1R: Macrophage colony-stimulating factor 1 receptor
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Tyrosine-protein kinase that acts as a cell-surface receptor for CSF1 and IL34 and plays an essential role in the regulation of survival, proliferation and differentiation of hematopoietic precursor cells, especially mononuclear phagocytes, such as macrophages and monocytes.
- Drugs that act on it: 18
- With a US drug page: 5
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Axatilimab | Approved | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
| Pazopanib | Approved | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | Boxed warning |
| Pexidartinib | Approved | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | Boxed warning |
| Quizartinib | Approved | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | Boxed warning |
| Sunitinib | Approved | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | Boxed warning |
| AMG-820 | — | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
| ARRY-382 | — | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
| Cabiralizumab | — | Macrophage colony stimulating factor receptor antagonist | Antagonist | — |
| CT-1578 | — | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
| Edicotinib | — | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
| Emactuzumab | — | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
| ENMD-2076 | — | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
| IMC-CS4 | — | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
| Linifanib | — | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
| PLX-5622 | — | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
| PLX-7486 | — | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
| Seralutinib | — | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
| Vatalanib | — | Macrophage colony stimulating factor receptor inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Leukoencephalopathy, diffuse hereditary, with spheroids 1
- 0.84
- Brain abnormalities, neurodegeneration, and dysosteosclerosis
- 0.79
- Neoplasm
- 0.59
- Leukoencephalopathy, hereditary diffuse, with spheroids
- 0.56
- Pigmented villonodular synovitis
- 0.53
- Neuroendocrine neoplasm
- 0.52
- Sarcoma
- 0.51
- Tenosynovial giant cell tumor
- 0.50
- Hereditary disease
- 0.49
Drugs and mechanisms are from ChEMBL CHEMBL1844 (CC BY-SA 3.0). Gene name, function (UniProt P07333, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets